Ipilimumab vs Lamotrigine
Ipilimumab vs Lamotrigine: Overview
This comparison examines the pharmacological differences between Ipilimumab and Lamotrigine.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Lamotrigine: Sodium channel blocker inhibiting glutamate release.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Lamotrigine β 25 hours.
Chemical Properties
Molecular Formula: Lamotrigine β C9H7Cl2N5.
Molecular Weight: Lamotrigine β 256.0910 g/mol.
Type: Ipilimumab β Antibody; Lamotrigine β Small molecule.